News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Héctor Vaquera: Low-Dose Anti-PD1 Immune Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma
Héctor Vaquera/X
May 24, 2025, 07:28

Héctor Vaquera: Low-Dose Anti-PD1 Immune Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma

Héctor Vaquera, Research trainee at Hematology Department of UANL, shared a post on X:

“New publication
Here we synthethized available evidence on the use of low-doses of nivolumab for r/r HL, an alternative not-so-rarely used in LMICs.”

Title: Low-Dose Anti-PD1 Immune Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Systematic Review

Authors: Héctor A. Vaquera-Alfaro, José Emiliano Montelongo-Cepeda, Antonio Vega-Mateos, Anahí Morales-Pedraza, Haydeé Verduzco-Aguirre, David Gómez Almaguer, Luis Villela, Perla R. Colunga-Pedraza

You can read the Full Article on JCO Global Oncology.

Héctor Vaquera: Low-Dose Anti-PD1 Immune Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma

More posts featuring Héctor Vaquera.

Anahí Morales-Pedraza Anti-PD1 Immune Checkpoint Inhibitors Antonio Vega-Mateos cancer Cancer research David Gomez-Almaguer Haydee Verduzco-Aguirre Héctor A. Vaquera-Alfaro Hodgkin lymphoma Immune Checkpoint Inhibitors José Emiliano Montelongo-Cepeda Luis Villela OncoDaily Oncology Perla R. Colunga-Pedraza
Special Coverage
Blog
Jun 9, 2025, 02:00
Irena Joveva: Health has no borders, and silence is not an option
Blog
Jun 9, 2025, 01:16
Wafik S. El-Deiry: Leading Discussions of our Legorreta Cancer Center Research Program Leaders
Oncolibrary
Jun 8, 2025, 17:28
ASCO 2025 Plenary Highlights: Key Practice-Changing Data Across TOP 5 ATOMIC, MATTERHORN, SERENA-6, VERIFY, and NIVOPOSTOP Trials
Blog
Jun 8, 2025, 17:04
Kimryn Rathmell Highlighted BuckeyeThon Students Raising Pediatric Blood Cancer Awareness at Farmers Market
Career
Jun 8, 2025, 17:03
Herbert Loong Joined IASLC Communications Committee For the 2025-2027 Term
Insight
Jun 8, 2025, 17:00
Christian Rolfo Highlighted VISION Trial Findings on METex14 NSCLC Detection Using Liquid and Tissue Biopsies
Blog
Jun 8, 2025, 16:58
Wafaa M Rashed: Final Words to the Eighth Cohort of the Policy Advocacy in Genetics and Genomics Course
Insight
Jun 8, 2025, 16:57
Akhil Santhosh Reflected on Experience with Dana-Farber’s Breast Oncology Team Through ASCO IDEA Program
Insight
Jun 8, 2025, 16:55
Al-Ola Abdallah Shared 2025 MIDAS Trial on MRD-Guided Myeloma Therapy Published in NEJM
Insight
Jun 8, 2025, 16:53
Talha Badar Shared an Article Published in Blood, ASH Journal
Insight
Jun 8, 2025, 16:48
Arndt Vogel Highlighted Phase II PANACHE01 Trial on Neoadjuvant FOLF(IRIN)OX for Resectable PDAC
Insight
Jun 8, 2025, 16:46
Giannis Mountzios Highlighted ASCO25 DeLLphi-304 Trial Featuring Tarlatamab Progress